MDXG News and Press, MiMedx Group Inc From 06/15/22

Image Analysis Group to Provide Imaging Strategy and Advanced Imaging Analytics in Support of MIMEDX’s Knee Osteoarthritis Clinical Trial Program MARIETTA, Ga., June 15, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Compan...

Prescience Point Capital Management Says MiMedx Shareholders Have Spoken: Voiced Their Desire For Change PR Newswire Notes that a Majority of the Non-Affiliated, Non-Institutional Shares Voted Against the Re-Election of Incumbent Directors, and Against Approval of Ex...

Dr. Phyllis Gardner and James L. Bierman Reelected to Board of Directors Company Also Receives Approvals for Say-on-Pay Proposal and Qualified Employee Stock Purchase Plan MARIETTA, Ga., June 07, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ: MDXG) (“MIMEDX&#x...

Prescience Point Capital Management Calls On MiMedx Group to Immediately Release Preliminary Voting Results of its Annual Meeting PR Newswire Believes That a Massive Number of Shares Voted Against the Re-Election of Incumbent Directors and Against Approval of Executive...

Deadline to Pre-Register is 9:00 a.m. Eastern Time on June 6, 2022 Pre-Registration Required to Attend Annual Meeting Visit www.votemimedx.com for Instructions on How to Pre-Register MARIETTA, Ga., June 03, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (N...

Company Highlights Factually Accurate Information Already Provided Urges Shareholders to Vote “FOR” MIMEDX’s Highly Qualified and Independent Directors – James L. Bierman and Phyllis Gardner, M.D. On the WHITE Proxy Card Today MARIETTA, Ga., June ...

Urges Shareholders to Vote “FOR” MIMEDX’s Highly Qualified and Independent Directors – James L. Bierman and Phyllis Gardner, M.D. on the WHITE Proxy Card Today MARIETTA, Ga., May 31, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ: MDXG) (“MI...

Prescience Point Capital Management Releases Presentation Detailing Board And Management Failures at MiMedx Group PR Newswire Votes WITHHOLD against board directors Phyllis Gardner and James Bierman at 2022 Annual Meeting to send a message to MiMedx Dem...

MiMedx Group (NASDAQ:MDXG) has received a $4.6M award from the US Department of Defense to evaluate its Purion processed Dehydrated Human Amnion Chorion Membrane (DHACM) as a treatment option for wound and burn care. The award will be managed and sponsored by the Naval Medical Research Center...

Funding Enables Evaluation of PURION ® Processed Placental Tissue as an Innovative Approach in the Management of Acute Military-Related Injuries, Addressing a Critical Unmet Need MARIETTA, Ga., May 31, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIME...